Takeda pulls dengue vaccine application after FDA requests more data
Takeda has withdrawn an FDA application for its dengue vaccine candidate following a request by regulators for more data.
The Japanese biotech filed a biologics …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.